## Abstract ## BACKGROUND The current study was conducted to characterize the impact of a prior malignancy on the diagnosis, treatment, and outcome of high‐grade glioma. ## METHODS A retrospective study of 21 patients with a histologic diagnosis of glioblastoma multiforme (GBM), anaplastic astro
Preradiation chemotherapy for pediatric patients with high-grade glioma
✍ Scribed by Johannes E. A. Wolff; Astrid K. Gnekow; Rolf-Dieter Kortmann; Thorsten Pietsch; Christian Urban; Norbert Graf; Joachim Kühl
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 208 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Doxorubicin exhibits high efficacy in malignant glioma cell cultures. Nonetheless, as a standard formulation, doxorubicin has not been used clinically, due to poor penetration of the blood‐brain barrier. Furthermore, doxorubicin is known to induce tumor resistance genes.
## Abstract ## BACKGROUND. Carboplatin‐based regimens have demonstrated activity in pediatric patients with low‐grade glioma (LGG). However, carboplatin hypersensitivity reaction (Cb HSR) represents a common and limiting factor for the continuation of therapy. ## METHODS. The objectives of this
## Background: High grade astrocytomas account for approximately 40% of all primary brain tumors. the median survival is approximately 8-10 months for patients with glioblastoma multiforme and 36 months for patients with anaplastic astrocytoma. the results of systemic chemotherapy in the treatment
BACKGROUND. The diagnosis of leptomeningeal dissemination of malignant glioma (meningeal gliomatosis) is associated with poor survival. Intrathecal (IT) chemotherapeutic agents used to achieve tumor control and improve survival include methotrexate, cytosine arabinoside (ara-C), thiotriethylenephosp